<p>Mice were treated as described in Fig. 1. Lung digests were performed, as described in the methods, cell populations were analysed by flow cytometry. (a) Total cell counts, (b) Total CD4+ T cell, (c) CD4+ CD25+Foxp3+ (Treg) cells and (d) CD4+CD25+ Foxp3− (activated T cells) in lung digests of sensitized mice following three challenges with saline, LPS-rich OVA and LPS-free OVA. (e) <i>in vitro</i> splenocyte Treg induction in the presence of the TAK-242 inhibitor with or without LPS-rich OVA and LPS-free OVA. Values are shown as Mean ± SEM. (n = 7). Statistical significance was determined using ANOVA.</p
<p>(A) Mice (C57BL/6) received CFSE-labeled OVA-specific OT-II T cells (10<sup>7</sup>/mouse) <i>i.v...
<p>(A) 1×10<sup>5</sup> CD90-selected splenic T cells of mice challenged with 291OVA cells were rest...
<p>(A) Lung draining LN were collected and restimulated <i>in vitro</i> with or without Ova (10 μM) ...
<p><b>(A)</b> Number of CD4<sup>+</sup> T cells in the lungs of PBS-treated or OVA-immunized GFP-C5a...
<p>Cytokine concentrations were measured in the BALF samples (A). The lymphocytes were activated by ...
<p>Both mLN and spleen cell suspensions were prepared 14 days after the start of the DSS and OVA tre...
<p>The percentages of FITC−OVA+ of iDCs and MHC II+ of FITC-OVA iDCs were measured by flow cytometry...
<p>WT or RAGE−/− mice were challenged with intranasal OVA as described in <a href="http://www.ploson...
<p>RAGE sufficient or deficient OT-II TCR-Tg mice were immunized with intranasal OVA as described in...
<p>Mice were treated as describe in Fig. 1, with three OVA challenges, and leukocytes were identifie...
<p>(a) Lung resistance in LPS-rich and LPS-free OVA challenged mice 48 hours following three OVA cha...
<p>Typical plots depicting numbers of Tregs in mouse splenocytes (a) and mesenteric lymph node (b) i...
<p>Mice were either treated with DSS alone or with DSS and OVA. Spleens and mLNs were removed, stimu...
<p>(A) OVA subcutaneous asthma induction protocol. (B) Differential BAL cytospins cell counts. (C) L...
<p>Lymph node and lung tissues from groups of wild type or B cell KO mice challenged with saline or ...
<p>(A) Mice (C57BL/6) received CFSE-labeled OVA-specific OT-II T cells (10<sup>7</sup>/mouse) <i>i.v...
<p>(A) 1×10<sup>5</sup> CD90-selected splenic T cells of mice challenged with 291OVA cells were rest...
<p>(A) Lung draining LN were collected and restimulated <i>in vitro</i> with or without Ova (10 μM) ...
<p><b>(A)</b> Number of CD4<sup>+</sup> T cells in the lungs of PBS-treated or OVA-immunized GFP-C5a...
<p>Cytokine concentrations were measured in the BALF samples (A). The lymphocytes were activated by ...
<p>Both mLN and spleen cell suspensions were prepared 14 days after the start of the DSS and OVA tre...
<p>The percentages of FITC−OVA+ of iDCs and MHC II+ of FITC-OVA iDCs were measured by flow cytometry...
<p>WT or RAGE−/− mice were challenged with intranasal OVA as described in <a href="http://www.ploson...
<p>RAGE sufficient or deficient OT-II TCR-Tg mice were immunized with intranasal OVA as described in...
<p>Mice were treated as describe in Fig. 1, with three OVA challenges, and leukocytes were identifie...
<p>(a) Lung resistance in LPS-rich and LPS-free OVA challenged mice 48 hours following three OVA cha...
<p>Typical plots depicting numbers of Tregs in mouse splenocytes (a) and mesenteric lymph node (b) i...
<p>Mice were either treated with DSS alone or with DSS and OVA. Spleens and mLNs were removed, stimu...
<p>(A) OVA subcutaneous asthma induction protocol. (B) Differential BAL cytospins cell counts. (C) L...
<p>Lymph node and lung tissues from groups of wild type or B cell KO mice challenged with saline or ...
<p>(A) Mice (C57BL/6) received CFSE-labeled OVA-specific OT-II T cells (10<sup>7</sup>/mouse) <i>i.v...
<p>(A) 1×10<sup>5</sup> CD90-selected splenic T cells of mice challenged with 291OVA cells were rest...
<p>(A) Lung draining LN were collected and restimulated <i>in vitro</i> with or without Ova (10 μM) ...